FindTrial
Sign In

Correlation between serum biomarkers, location of endometriosis lesion, and clinical presentation

Correlation between serum biomarkers, location of endometriosis lesion, and clinical presentation - Serume biomarkers in endometriosis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000032645
Enrollment
2000
Registered
2018-05-19
Start date
2009-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

None listed

Sponsors

Policlinico of Abano Terme
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Evidence (at ultrasound and/or MRI) or suspect of pelvic endometriosis; surgical treatment (laparoscopy); serum biomarkers evaluation;

Exclusion criteria

Exclusion criteria: Age less that 16 years; no evidence of endometriosis at surgery; previous diagnosis of fibromyalgia

Design outcomes

Primary

MeasureTime frame
Correspondence between serum biomarkers evaluated before surgery, clinical manifestations, and pelvic sites where endometriosis lesions are found at laparoscopy.—

Secondary

MeasureTime frame
Clinical interpretation of each biomarker (Ca125, Ca 19.9, Ca 15.3) in endometriosis—

Countries

Europe

Contacts

Public ContactMarco Scioscia

Policlinico of Abano Terme Obstetrics and Gynecology

marcoscioscia@gmail.com+393498724206

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026